HOME › DRUGS › ELVITEGRAVIR, COBICISTAT, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE
ACTIVE SUBSTANCE / INN

ELVITEGRAVIR, COBICISTAT, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE

Brand name(s): ELVITEGRAVIR, COBICISTAT, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE
FDA LISTED
NONE (TENTATIVE APPROVAL)
ANDA218575
ACTIVE SUBSTANCE
Elvitegravir, Cobicistat, Emtricitabine And Tenofovir Alafenamide
REGULATORS
FDA
SPONSORS / MAH
APOTEX INC
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
ELVITEGRAVIR, COBICISTAT, EMTRICITABINE AND TENOFOVIR ALAFENAMIDEANDA218575APOTEX INCNone (Tentative Approval)

FULL INTELLIGENCE ON ELVITEGRAVIR, COBICISTAT, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →